novocure(NVCR) - 2024 Q2 - Earnings Call Presentation
novocure(NVCR)2024-07-25 14:47novocure® Novocure Q2 2024 Earnings Thursday, July 25, 2024 CONTRAINDICATIONS novocure® use and important safety information · If the patient has an underlying serious skin condition on the treated area, evaluate whether this may prevent or temporarily interfere with Optune Gio or Optune Lua treatment. © 2024 Novocure GmbH 9 © 2024 Novocure GmbH 10 patientforward® © 2024 Novocure GmbH forward-looking statements The statements contained in this presentation are made as at the date of this presentation, unles ...